Delta clinical trials

While Pfizer and BioNTech believe a third dose of BNTb2 has the potential to preserve the highest levels of protective efficacy against all currently known variants including Delta, the companies are remaining vigilant and are developing an updated version of the Pfizer-BioNTech COVID vaccine that targets the full spike protein of the Delta variant.

The first batch of the mRNA for the trial has already been manufactured. The Companies anticipate the clinical studies to begin in August, subject to regulatory approvals.

Its current transmission rate among fully vaccinated and unvaccinated is quite similar according to the CDC, though vaccinated in US reportedly have more symptomless cases. Israel, one of the countries to vaccinate most of its population early, is having a majority of its severe cases in the fully vaccinated according to latest reports , and is embarking on administering a third dose of the vaccines.

Because we recognized the threat of Fake news quite early in the game, we established NewsRescue since to be at the forefront in filtering the news to give you only the essential and important real stories. No BS, no junk, no fake news. Contact us: [email protected]. For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government.

Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Last Update Posted : January 11, See Contacts and Locations. Study Description. MedlinePlus related topics: Melanoma. FDA Resources. E: info deltaclinical. Patient-centric clinical trial design Over the years, an increase in competition within the drug development industry and the complexity of products and protocols, has led to a search for new strategies with the aim of being more efficient, having a higher patient engagement and speeding up the study timelines.

There are many different ways to make a trial more patient-centric, such as: recruiting patients through social media study branded schedules and guides designed to educate and inform the patient reporting through applications online informed consent open communication data transparency patient-centred outcomes video conferencing … One other way to make a trial more patient-centric, is to bring the trial to the patient instead of the patient to the trial through the implementation of home visits.

Please leave your message and we will contact you as soon as possible. Your contact data will be used for information purposes only. For the patient, a home visit is much more pleasant than a hospital visit.

This results in more successful recruitment, higher compliance and less dropout. Our study coordinators can conduct full studies, or they can provide reinforcement during peak times. We are used to recruiting patients for studies and keeping them motivated and encouraged to participate till the end of the clinical trial. A big added value here are our home care services. E info deltaclinical.